Multi Indocitra Tbk PT operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Multi Indocitra Tbk PT with three other
drug stores in Asia:
Mustika Ratu Tbk PT
sales of 458.20 billion Indonesian Rupiahs [US$40.14 million]
of which 98%
was Trading and Distribution),
GuangYuYuan Chinese Herbal Medicine Co Ltd
(259.93 million Chinese Renmimbi [US$41.76 million]
of which 99%
was Drug Distribution), and
Sharehope Medicine Company Limited
based in Taiwan
(1.83 billion Taiwanese Dollars [US$60.72 million]
of which 59%
was Medical Business).
During the year ended December of 2012, sales at
Multi Indocitra Tbk PT were 560.03 billion Indonesian Rupiahs (US$49.06 million).
increase of 20.4%
versus 2011, when the company's sales were 465.31 billion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Multi Indocitra Tbk PT
(and since 2007, sales have increased a total of 130%).
Sales of Trading saw an increase
22.6% in 2012, from
409.49 billion Indonesian Rupiahs to 501.99 billion Indonesian Rupiahs.
Not all segments of Multi Indocitra Tbk PT experienced an increase in sales in 2012:
sales of Industry fell 70.5% to 58.04 billion Indonesian Rupiahs.